2021
DOI: 10.1016/j.encep.2020.09.010
|View full text |Cite
|
Sign up to set email alerts
|

La pharmacorésistance aux psychotropes chez l’enfant et l’adolescent : recherche d’anomalies pharmacogénétiques du cytochrome P450 2D6

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Therefore, genetic pro ling in drug metabolism may help guide clinical treatment in psychiatric diseases (13). However, additional evidence is needed to con rm the role of the ultra-rapid phenotype of CYP genes in the treatment of psychotropic drugs, and pharmacogenetic analysis in drug transport and action may also play an important role (14). In addition, age and body weight are other factors involved in the safety and e cacy of APs by in uencing pharmacokinetics (15,16).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, genetic pro ling in drug metabolism may help guide clinical treatment in psychiatric diseases (13). However, additional evidence is needed to con rm the role of the ultra-rapid phenotype of CYP genes in the treatment of psychotropic drugs, and pharmacogenetic analysis in drug transport and action may also play an important role (14). In addition, age and body weight are other factors involved in the safety and e cacy of APs by in uencing pharmacokinetics (15,16).…”
Section: Introductionmentioning
confidence: 99%